Insurance firms target top-ups

Health insurance companies are looking to capitalise on the government's U-turn on top-up treatments.

Following the announcement by health secretary Alan Johnson that patients who buy drugs privately will no longer be denied NHS treatment, insurers are looking at developing new insurance policies.

Standard Life said that although the market for policies covering drugs not funded by the NHS might be small, products could be developed to meet consumer demand to have certain treatments privately and others on the NHS.

Natalie Jane Macdonald, managing director of Bupa UK Health Insurance, said: 'We want to develop products that provide people with peace of mind about their healthcare and will consider all opportunities.'

Norwich Union said it welcomed Mr Johnson's announcement and would like to see the government taking into account 'wider treatment options'.

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Follow Us:

Just published

GP consulting room

Nine in ten GPs fear their practice will struggle to cope this winter

Nearly nine in ten GPs fear that their practice will struggle to cope this winter,...

UK money

Almost half of practices say income from private fees has fallen in past year

Almost half of GP practices have seen their income from private and professional...

COVID-19 vaccination centre

BMA raises 'serious concerns' about GP workload and funding for autumn COVID boosters

The BMA has raised 'serious concerns' about the workload implications of this autumn's...


Monkeypox jabs will run out by next week, UKHSA says

The UK is likely to run out of smallpox vaccine stocks which it is using to protect...

NHS sign outside a building

Two Midlands hospitals end partnerships with Babylon

Two NHS trusts have prematurely severed their relationships with digital health provider,...

Person receiving a COVID-19 booster

JCVI sets out which vaccines to use for autumn COVID-19 boosters

The Joint Committee on Vaccinations and Immunisations (JCVI) has said that Moderna's...